Docetaxel cost-saving alternative to abiraterone in prostate cancer
Source: PharmacoEconomics and Outcomes News - Category: Drugs & Pharmacology Source Type: news
More News: Cancer | Cancer & Oncology | Docetaxel | Drugs & Pharmacology | Prostate Cancer | Taxotere